Exosomes in malignant pleural effusion from lung cancer patients impaired the cytotoxicity of double-negative T cells

Jingjing Wu,Ranran Zhu,Zhengxia Wang,Xueqin Chen,Tingting Xu,Yanan Liu,Meijuan Song,Jingxian Jiang,Qiyun Ma,Zhongqi Chen,Yuan Liu,Xiaoyue Wang,Mingshun Zhang,Mao Huang,Ningfei Ji

DOI: https://doi.org/10.1016/j.tranon.2022.101564

Abstract:CD3+CD4-CD8- double-negative T (DNT) cells are new weapons in cancer immunotherapy. Here, we explored DNT cells in malignant pleural effusions (MPEs) from lung cancer patients. DNT cells, especially TCRαβ+CD56- DNT cells, were increased in MPE from lung cancer patients. DNT cells highly expressed PD-1, TRAIL, NKG2D and DNAM-1. In contrast, FasL was barely detected in DNT cells. Compared with non-MPE cells, MPE-derived DNT cells expressed much higher levels of PD-1 and TRAIL. DNT cells from healthy peripheral blood donors potentially killed lung cancers, which was decreased by MPE supernatant. Exosomes from MPE supernatant expressed PD-1 and CEACAM1 and impaired the cytotoxicity of DNT cells. Blocking PD-1 and TIM3 rescued the cytotoxicity of DNT cells treated with MPE-derived exosomes. Overall, we demonstrated that the frequency of DNT cells in MPE from lung cancer patients was increased and that MPE-derived exosomes impaired the cytotoxicity of DNT cells via the PD-1/PD-L1 and CEACAM1/TIM3 pathways.